The decision could encourage other states to take aim at drugmaker restrictions on where providers can use discounts.
Adriel Bettelheim is a Senior Healthcare Editor for Axios, with a focus on national healthcare issues, particularly in the United States and the Tampa Bay area. His work has been featured in POLITICO and Yahoo News, and he covers a wide range of topics including FDA regulations, healthcare policy, pharmaceutical developments, and the impact of healthcare decisions on the American public.